What is he best known for?
The fields of study he is best known for:
Peter Vandenabeele spends much of his time researching Cell biology, Programmed cell death, Apoptosis, Caspase and Necroptosis.
His Cell biology research is multidisciplinary, incorporating perspectives in Tumor necrosis factor alpha, Cell and Receptor.
His studies deal with areas such as Necrosis, Autophagy and Intracellular as well as Programmed cell death.
His studies examine the connections between Apoptosis and genetics, as well as such issues in Neuroscience, with regards to Mitotic catastrophe.
His Caspase research is multidisciplinary, incorporating elements of Proteases, Molecular biology, Caspase 1 and Cellular differentiation.
The Necroptosis study combines topics in areas such as Cancer research, Kinase activity, Protein kinase A and Mitochondrial permeability transition pore.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 (2566 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cell biology, Apoptosis, Programmed cell death, Tumor necrosis factor alpha and Raman spectroscopy.
He interconnects Caspase, Cell and Receptor in the investigation of issues within Cell biology.
His work carried out in the field of Apoptosis brings together such families of science as Inflammation, Immunology, Molecular biology and Mitochondrion.
A large part of his Programmed cell death studies is devoted to Necroptosis.
His Tumor necrosis factor alpha study combines topics from a wide range of disciplines, such as Cytokine and In vivo.
His studies in Raman spectroscopy integrate themes in fields like Spectrometer, Painting and Mineralogy.
He most often published in these fields:
- Cell biology (37.38%)
- Apoptosis (26.44%)
- Programmed cell death (25.84%)
What were the highlights of his more recent work (between 2016-2021)?
- Programmed cell death (25.84%)
- Necroptosis (13.46%)
- Cell biology (37.38%)
In recent papers he was focusing on the following fields of study:
Peter Vandenabeele focuses on Programmed cell death, Necroptosis, Cell biology, Cancer research and Apoptosis.
His Programmed cell death study integrates concerns from other disciplines, such as Tumor necrosis factor alpha, Cell, Oxidative stress, Necrosis and In vivo.
His study in Necroptosis is interdisciplinary in nature, drawing from both Pyroptosis, Immunogenic cell death and Kinase, Kinase activity.
The concepts of his Pyroptosis study are interwoven with issues in Caspase and Caspase 1.
His Cell biology study frequently links to adjacent areas such as Inflammasome.
His Cancer research study incorporates themes from Cancer cell and Immune system.
Between 2016 and 2021, his most popular works were:
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. (1421 citations)
- The molecular machinery of regulated cell death (299 citations)
- The molecular machinery of regulated cell death (299 citations)
In his most recent research, the most cited papers focused on:
Peter Vandenabeele mainly investigates Programmed cell death, Necroptosis, Cell biology, Cancer research and Apoptosis.
His work deals with themes such as Tumor necrosis factor alpha, Necrosis, Pharmacology and In vivo, which intersect with Programmed cell death.
His biological study spans a wide range of topics, including NFKB1 and Kinase.
His research brings together the fields of Cell and Cell biology.
His Cancer research research is multidisciplinary, relying on both Cancer cell, Death domain, Carcinogenesis and Bile Duct Adenoma.
His Apoptosis research includes themes of Hepatocyte and Hepatitis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
